Claritev Past Earnings Performance
Past criteria checks 0/6
Claritev's earnings have been declining at an average annual rate of -39.3%, while the Healthcare Services industry saw earnings growing at 16.5% annually. Revenues have been declining at an average rate of 1.5% per year.
Key information
-39.30%
Earnings growth rate
-36.80%
EPS growth rate
| Healthcare Services Industry Growth | 1.72% |
| Revenue growth rate | -1.49% |
| Return on equity | n/a |
| Net Margin | -70.91% |
| Last Earnings Update | 30 Jun 2025 |
Recent past performance updates
Recent updates
Claritev Corporation's (NYSE:CTEV) Share Price Boosted 27% But Its Business Prospects Need A Lift Too
Sep 09
Claritev's Stock Performance Could Be Shooting Past Q2 Performance: I Choose A Hold Rating
Aug 15Claritev (NYSE:CTEV) Use Of Debt Could Be Considered Risky
Jul 30Claritev Corporation's (NYSE:CTEV) Price Is Right But Growth Is Lacking After Shares Rocket 25%
Jul 09
AI And Global Partnerships Will Reshape Personalized Medicine
AI-powered analytics, digital transformation, and global expansions position Claritev to monetize higher-value healthcare solutions and tap into growing, aging populations.Claritev Corporation (NYSE:CTEV) Shares Fly 30% But Investors Aren't Buying For Growth
May 15Little Excitement Around Claritev Corporation's (NYSE:CTEV) Revenues As Shares Take 28% Pounding
Mar 20There's No Escaping MultiPlan Corporation's (NYSE:MPLN) Muted Revenues Despite A 29% Share Price Rise
Feb 03MultiPlan Corporation (NYSE:MPLN) Stock Catapults 28% Though Its Price And Business Still Lag The Industry
Dec 20Here's Why MultiPlan (NYSE:MPLN) Is Weighed Down By Its Debt Load
Dec 13MultiPlan Corporation (NYSE:MPLN) Shares Fly 55% But Investors Aren't Buying For Growth
Oct 20MultiPlan Corporation (NYSE:MPLN) Not Doing Enough For Some Investors As Its Shares Slump 40%
Aug 18Little Excitement Around MultiPlan Corporation's (NYSE:MPLN) Revenues As Shares Take 46% Pounding
Jul 04MultiPlan (NYSE:MPLN) Use Of Debt Could Be Considered Risky
Jul 02MultiPlan Corporation (NYSE:MPLN) Looks Inexpensive After Falling 29% But Perhaps Not Attractive Enough
May 09Estimating The Intrinsic Value Of MultiPlan Corporation (NYSE:MPLN)
Apr 23Why Investors Shouldn't Be Surprised By MultiPlan Corporation's (NYSE:MPLN) 26% Share Price Plunge
Mar 13MultiPlan (NYSE:MPLN) Has A Somewhat Strained Balance Sheet
Mar 05Insufficient Growth At MultiPlan Corporation (NYSE:MPLN) Hampers Share Price
Jan 08MultiPlan Sees Uptick In Utilization But Revenue Growth Is A Challenge
Oct 27Revenues Working Against MultiPlan Corporation's (NYSE:MPLN) Share Price
Oct 02MultiPlan Sees Stabilizing Markets But Contracting Revenue In 2023
Jul 13Revenue & Expenses Breakdown
How Claritev makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Jun 25 | 936 | -663 | 179 | 0 |
| 31 Mar 25 | 927 | -1,177 | 176 | 0 |
| 31 Dec 24 | 931 | -1,646 | 160 | 0 |
| 30 Sep 24 | 943 | -1,539 | 142 | 0 |
| 30 Jun 24 | 955 | -1,172 | 142 | 0 |
| 31 Mar 24 | 959 | -632 | 140 | 0 |
| 31 Dec 23 | 962 | -92 | 136 | 0 |
| 30 Sep 23 | 958 | -710 | 102 | 0 |
| 30 Jun 23 | 966 | -667 | 124 | 0 |
| 31 Mar 23 | 1,018 | -617 | 133 | 0 |
| 31 Dec 22 | 1,080 | -573 | 132 | 0 |
| 30 Sep 22 | 1,137 | 102 | 158 | 0 |
| 30 Jun 22 | 1,175 | 161 | 136 | 0 |
| 31 Mar 22 | 1,161 | 100 | 135 | 0 |
| 31 Dec 21 | 1,118 | 102 | 141 | 0 |
| 30 Sep 21 | 1,075 | -96 | 197 | 0 |
| 30 Jun 21 | 1,010 | -463 | 334 | 0 |
| 31 Mar 21 | 941 | -472 | 330 | 0 |
| 31 Dec 20 | 938 | -521 | 323 | 0 |
| 30 Sep 20 | 929 | -335 | 254 | 0 |
| 30 Jun 20 | 951 | -42 | 104 | 0 |
| 31 Mar 20 | 990 | 11 | 87 | 0 |
| 31 Dec 19 | 983 | 10 | 75 | 0 |
| 31 Dec 18 | 1,041 | 36 | 78 | 0 |
| 31 Dec 17 | 1,067 | 648 | 123 | 0 |
Quality Earnings: CTEV is currently unprofitable.
Growing Profit Margin: CTEV is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: CTEV is unprofitable, and losses have increased over the past 5 years at a rate of 39.3% per year.
Accelerating Growth: Unable to compare CTEV's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: CTEV is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare Services industry (13.5%).
Return on Equity
High ROE: CTEV's liabilities exceed its assets, so it is difficult to calculate its Return on Equity.
Return on Assets
Return on Capital Employed
Discover strong past performing companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/10/07 22:09 |
| End of Day Share Price | 2025/10/07 00:00 |
| Earnings | 2025/06/30 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Claritev Corporation is covered by 5 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Steven Valiquette | Barclays |
| Andrew D'Silva | B. Riley Securities, Inc. |
| Daniel Grosslight | Citigroup Inc |